Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06231017
Status:
RECRUITING
Last Update Posted:
2024-01-30
First Post:
2024-01-21
Brief Title:
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RASBRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Organization Data
Organization:
The First Affiliated Hospital of Zhengzhou University
Class:
OTHER
Study ID:
S2023-K019-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Lead Sponsor Class:
OTHER
Responsible Party:
Hong Zong
Responsible Party Title:
A Single-arm Open-label Phase Ⅱ Clinical Trial of Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RASBRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital of Zhengzhou University
Old Name:
None
Old Organization:
None